{"id":"NCT00000142","sponsor":"Johns Hopkins Bloomberg School of Public Health","briefTitle":"Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)","officialTitle":"Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"1994-04","primaryCompletion":"1996-02","completion":"1996-02","firstPosted":"1999-09-24","resultsPosted":"2015-11-17","lastUpdate":"2015-11-17"},"enrollment":64,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections","CMV Cytomegalovirus Retinitis"],"interventions":[{"type":"DRUG","name":"Cidofovir","otherNames":["Vistide"]}],"arms":[{"label":"treatment deferral","type":"EXPERIMENTAL"},{"label":"Cidofovir (low dose)","type":"EXPERIMENTAL"},{"label":"Cidofovir (high dose)","type":"EXPERIMENTAL"}],"summary":"To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.","primaryOutcome":{"measure":"Survival","timeFrame":"All patients enrolled will be followed until a common study closing date","effectByArm":[{"arm":"Treatment Deferral","deltaMin":6,"sd":null},{"arm":"Cidofovir (Low Dose)","deltaMin":7,"sd":null},{"arm":"Cidofovir (High Dose)","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":17,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["9036798","10983644","9313009","31042791"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":26},"commonTop":["Serum creatinine level >= 133 umol/L (1.5 mg/dL)"]}}